Zacks Investment Management United Therapeutics Corp Transaction History

Zacks Investment Management

  • $11.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$205.95 - $280.43 $5,972 - $8,132
-29 Reduced 0.39%
7,457 $2.07 Million
Q3 2022

Nov 14, 2022
BUY
$203.3 - $244.17 $18,906 - $22,707
93 Added 1.26%
7,486 $1.57 Million
Q2 2022

Aug 15, 2022
BUY
$174.81 - $241.14 $1.29 Million - $1.78 Million
7,393 New
7,393 $1.74 Million

Others Institutions Holding UTHR

# of Institutions
681
Shares Held
42.2M
Call Options Held
194K
Put Options Held
298K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Zacks Investment Management Portfolio

Follow Zacks Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Zacks Investment Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email